These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39641162)

  • 1. Establishment and Validation of the Novel Necroptosis-related Genes for Predicting Stemness and Immunity of Hepatocellular Carcinoma
    Li YT; Zeng XZ
    Comb Chem High Throughput Screen; 2025; 28(1):146-165. PubMed ID: 39641162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enabling Systemic Identification and Functionality Profiling for Cdc42 Homeostatic Modulators.
    Malasala S; Azimian F; Chen YH; Twiss JL; Boykin C; Akhtar SN; Lu Q
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis and immune landscape of bladder cancer can be predicted using a novel miRNA signature associated with cuproptosis.
    Zhang Z; Liu F; Yu Y; Xie F; Zhu T
    PeerJ; 2024; 12():e18530. PubMed ID: 39624133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyroptosis-related long-noncoding RNA signature predicting survival and immunotherapy efficacy in patients with lung squamous cell carcinoma.
    Zhan X; Li J; Ding Y; Zhou F; Zeng R; Lei L; Zhang Y; Feng A; Qu Y; Yang Z
    Clin Exp Med; 2024 Jul; 24(1):145. PubMed ID: 38960987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the SORG Machine-learning Algorithm for Extremity Metastases Generalize to a Contemporary Cohort of Patients? Temporal Validation From 2016 to 2020.
    de Groot TM; Ramsey D; Groot OQ; Fourman M; Karhade AV; Twining PK; Berner EA; Fenn BP; Collins AK; Raskin K; Lozano S; Newman E; Ferrone M; Doornberg JN; Schwab JH
    Clin Orthop Relat Res; 2023 Dec; 481(12):2419-2430. PubMed ID: 37229565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Risk Factors, and Development and Validation of Prognostic Prediction Models for Distant Metastasis in Patients With Rectal Cancer: A Study Based on the SEER Database and a Chinese Population.
    Zhang H; Wang H; Yao Y; Liu L; Feng F; Li H; Sun C
    Cancer Control; 2024; 31():10732748241303650. PubMed ID: 39579008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Exploration of key ferroptosis-related genes as therapeutic targets for sepsis based on bioinformatics and the depiction of their immune profiles characterization].
    Li M; Mei Y; Pan A
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Oct; 36(10):1025-1032. PubMed ID: 39586719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of prediction models for fetal growth restriction and birthweight: an individual participant data meta-analysis.
    Allotey J; Archer L; Coomar D; Snell KI; Smuk M; Oakey L; Haqnawaz S; Betrán AP; Chappell LC; Ganzevoort W; Gordijn S; Khalil A; Mol BW; Morris RK; Myers J; Papageorghiou AT; Thilaganathan B; Da Silva Costa F; Facchinetti F; Coomarasamy A; Ohkuchi A; Eskild A; Arenas Ramírez J; Galindo A; Herraiz I; Prefumo F; Saito S; Sletner L; Cecatti JG; Gabbay-Benziv R; Goffinet F; Baschat AA; Souza RT; Mone F; Farrar D; Heinonen S; Salvesen KÅ; Smits LJ; Bhattacharya S; Nagata C; Takeda S; van Gelder MM; Anggraini D; Yeo S; West J; Zamora J; Mistry H; Riley RD; Thangaratinam S
    Health Technol Assess; 2024 Aug; 28(47):1-119. PubMed ID: 39252507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of malic enzyme 1 predicts adverse prognosis in patients with cytogenetically normal acute myeloid leukaemia and promotes leukaemogenesis through the IL-6/JAK2/STAT3 pathways.
    Zhang C; Li W; Wu F; Lu Z; Zeng P; Luo Z; Cao Y; Wen F; Li J; Chen X; Wang F
    Ther Adv Hematol; 2024; 15():20406207241301948. PubMed ID: 39610460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring Cuproptosis-Related Genes and Diagnostic Models in Renal Ischemia-Reperfusion Injury Using Bioinformatics, Machine Learning, and Experimental Validation.
    Xu C; Deng Y; Gong X; Wang H; Man J; Wang H; Cheng K; Gui H; Fu S; Wei S; Zheng X; Che T; Ding L; Yang L
    J Inflamm Res; 2024; 17():8997-9020. PubMed ID: 39583859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of abstinence-based and harm reduction-based interventions in reducing problematic substance use in adults who are experiencing homelessness in high income countries: A systematic review and meta-analysis: A systematic review.
    O'Leary C; Ralphs R; Stevenson J; Smith A; Harrison J; Kiss Z; Armitage H
    Campbell Syst Rev; 2024 Jun; 20(2):e1396. PubMed ID: 38645303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying the prognostic significance of mitophagy-associated genes in multiple myeloma: a novel risk model construction.
    Min R; Hu Z; Zhou Y
    Clin Exp Med; 2024 Oct; 24(1):249. PubMed ID: 39470826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results.
    Wing K; Williamson E; Carpenter JR; Wise L; Schneeweiss S; Smeeth L; Quint JK; Douglas I
    Health Technol Assess; 2021 Aug; 25(51):1-70. PubMed ID: 34463610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen for adults with hepatocellular carcinoma.
    Naing C; Ni H; Aung HH
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD014869. PubMed ID: 39132750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Risk Genes S1PR5, CMC1, and ASAH1 as Potential Targets for the Diagnosis, Immunotherapy, and Treatment of Colon Adenocarcinoma by Single-Cell and Bulk RNA Sequencing Analysis.
    Xu Z; Gong J; Hu W; Ge C; Tong G; Cai F; Zhu Z; Yuan Y; Chen C
    Curr Med Chem; 2024 Nov; ():. PubMed ID: 39513308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An arterial spin labeling-based radiomics signature and machine learning for the prediction and detection of various stages of kidney damage due to diabetes.
    Ma F; Shao X; Zhang Y; Li J; Li Q; Sun H; Wang T; Liu H; Zhao F; Chen L; Chen J; Zhou S; Ji Q; Yu P
    Front Endocrinol (Lausanne); 2024; 15():1333881. PubMed ID: 39624821
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.